Textile, Sea foods and organic chemical will be severely impacted because of 50% tariff: GTRI
The report highlighted that while the impact will vary across sectors, some of India's largest export categories may see a sharp fall in shipments to the U.S.
GTRI stated 'This decision makes India one of the most heavily taxed U.S. trading partners, worse off than China (30 per cent) or Vietnam (20 per cent), and on par with Brazil'.
Very high impact sectors include Shrimps, Organic Chemical, Carpets, Apparel, Diamond and Gold Jewellery.
The report also stated that exports in certain sectors could drop by 50-70 per cent.
Shrimps, which brought in USD 2 billion from the U.S. in FY2025 and account for 9.52 per cent of U.S. shrimp imports, will now face a 50 per cent tariff along with existing antidumping and countervailing duties of about 10 per cent. Competitors like Canada and Chile enjoy much lower tariffs.
Organic chemicals worth USD 2.7 billion exported from India will now face a total tariff of 54 per cent, compared to just 15 per cent for Ireland and 39 per cent for Switzerland.
Carpets, where India holds the largest U.S. market share at 35.48 per cent with exports of USD 1.2 billion, will be hit by a 52.9 per cent duty, making them less competitive against Turkey and China.
The apparel sector will also suffer heavily. Knitted apparel exports worth USD 2.7 billion will face a 63.9 per cent tariff, while woven apparel worth the same value will attract 60.3 per cent duty.
Made-ups, including bed linen and towels, will face a 59 per cent duty on USD 3 billion worth of exports. Diamonds, gold, and jewellery, India's top export sector to the U.S. at USD 10 billion, will now be taxed at 52.1 per cent.
Machinery and mechanical appliances worth USD 6.7 billion will see a 51.3 per cent duty, and furniture worth USD 1.1 billion will attract 52.3 per cent.
High impacting sectors, Steel, aluminium, and copper exports worth USD 4.7 billion will face a 51.7 per cent tariff, while auto parts worth USD 2.6 billion will be taxed at 26 per cent.
Some key sectors remain unaffected. as they are exempted from 50 per cent duty. Pharmaceuticals worth USD 9.8 billion, smartphones worth USD 10.6 billion, and petroleum products worth USD 4.1 billion will continue to face zero or minimal tariffs, giving them a competitive edge.
The report also warned that the high tariffs could significantly hurt India's market share in the U.S. for several sectors, especially those already facing strong competition from countries with lower or no tariffs. (ANI)
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Canada News.Net
25 minutes ago
- Canada News.Net
New South Korean Foreign Minister Cho Hyun to visit India from August 15-17
New Delhi [India], August 14 (ANI): South Korea's newly appointed Minister of Foreign Affairs, Cho Hyun, will be visiting India from August 15 to 17, as per the Ministry of External Affairs (MEA). The MEA said in a media advisory on Thursday that the South Korean Foreign Minister would arrive in New Delhi on Friday evening and meet External Affairs Minister Dr S Jaishankar on Saturday. The visit is expected to focus on strengthening strategic cooperation between India and South Korea in areas such as: semiconductors, green hydrogen, trade and maritime security. Cho Hyun's visit is part of India's efforts to boost its engagement with Asia, particularly in the Indo-Pacific region. He was previously India's ambassador from 2015 to 2017 and has expertise in multilateral diplomacy. Cho Hyun recently spoke with Dr. Jaishankar, discussing deepening bilateral ties between the two countries. Earlier on July 28, in a post on X, EAM Jaishankar had conveyed his best wishes to the South Korean counterpart for a successful tenure. On July 21, External Affairs Minister Dr S Jaishankar congratulated Cho Hyun on his appointment as the new Foreign Minister of South Korea. In a post on X, he expressed confidence in working together to further strengthen the ties between the two countries and toward achieving a Special Strategic Partnership between New Delhi and Seoul. Earlier in July, Prime Minister Narendra Modi had received a delegation of special envoys from South Korea and highlighted the completion of 10 years of India-South Korea partnership. He underlined that the close collaboration between the two countries plays a key role in the Indo-Pacific region. On the same day, the EAM also met a delegation of special envoys from the Republic of Korea (RoK), led by former Prime Minister Kim Boo-kyum, which was visiting India and discussed ways to strengthen bilateral ties in key areas including economy, technology, defence, maritime security, and people-to-people meeting comes amid renewed efforts from both sides to boost cooperation across sectors such as green hydrogen, shipbuilding, investment, semiconductors, and regional security, especially in the Indo-Pacific. The visit had come after Prime Minister Narendra Modi and South Korean President Lee Jae Myung met on the sidelines of the G7 Summit in Canada last month. Both leaders expressed commitment to working together in trade, investment, green energy, and emerging technology sectors. (ANI)
Calgary Herald
2 hours ago
- Calgary Herald
Chorney-Booth: Kondattam is a pan-Indian dream come true
Article content While many Asian restaurants in Calgary are opting to go more regional these days, Thangavel and Senniappan decided to make Kondattam a pan-Indian affair or, as Sennaippan likes to say, 'from Kashmir to Kanyakumari' or 'K to K,' referencing a popular north-to-south Indian road trip route. The menu is quite large — though, Sennaippan notes, significantly more curated than a typical curry house menu — with selections representing the best of Indian cuisine. You've got snacks like pani puri ($10) balls stuffed with potatoes and green peas; a fried squid appetizer with house masala ($18); ultra-crisp dosas ($10) with plenty of filling options; and five flavours of naan ($3 to $7). Article content Everything on the menu is prepared with great skill and care, but there are some must-try standouts. While Senniappan did put the obligatory butter chicken on the menu, he's pleased that the most popular curry has been the fragrant Kondattam signature curry, made with a blend of 16 spices from the Karaikudi region of Tamil Nadu. The tandoor section of the menu also has some interesting choices, including fresh Atlantic salmon cooked in the charcoal tandoor ($24) and an Alberta sirloin steak ($26) prepared in the tandoor and served in a tomato butter curry. Article content Article content Thangavel and Senniappan aimed high, bringing their dream and spices from halfway around the world. Already almost constantly full of customers, it's turning out to be a dream come true for Calgarians, too. Article content Kondattam is located at 1006 1st St. S.E. in the Upten Apartments building. The restaurant is open Tuesday through Sunday for lunch and dinner and can be reached at 403-453-0078 or through Article content In other food news, knowing where our food comes from is important, which is why agri-tourism is so popular. The annual Open Farm Days takes place this weekend (Aug. 16 and 17), with farms throughout the province welcoming the public to tour their properties and see how the food we enjoy is produced. Pay a visit to well-known operations like Edgar Farms near Innisfail or Spirit Hills flower winery in Millarville, or take a chance and try a new-to-you greenhouse, honey producer, cattle ranch or fresh flower grower. There's a lot to explore: the full list of participants can be found at
The Market Online
3 hours ago
- The Market Online
BOMBSHELL! RENK, Bayer, Desert Gold! Who has the potential to multiply?
Bombshell at RENK! Order intake is exploding! Revenue and earnings are also already up significantly. After Rheinmetall and Hensoldt posted rather disappointing figures, the defense boom appears to be reaching the tank transmission specialist. The stock is reacting strongly. Meanwhile, the share price of gold explorer Desert Gold (TSXV:DAU) has not yet responded to the recent Preliminary Economic Assessment (PEA). This is surprising, as the returns are high – even with the conservative gold price assumptions. In an interview with analysts, the CEO once again explains the opportunities. GBC Research sees potential for multiplication here. At Bayer, investors have recently been focusing more on litigation risks in the US than on upside potential. However, the latest news from the pharmaceutical division is driving the Leverkusen-based company's shares up again. Is the weak phase finally over? This article is disseminated in partnership with Apaton Finance GmbH. It is intended to inform investors and should not be taken as a recommendation or financial advice. Desert Gold: An opportunity in the gold sector Desert Gold (TSXV:DAU) currently offers an opportunity in the gold sector. Last week, the long-awaited Preliminary Economic Assessment (PEA) for the SMSZ project in West Africa was published. Despite strong prospects, Desert Gold's share price has hardly reacted. Yesterday, Desert CEO Jared Scharf clarified in an interview with analysts from GBC Research that the study reflects only a fraction of the actual potential. According to this, only around 10% of the current gold resource of 1.1 million ounces was taken into account. Based on a gold price of USD 2,500 per ounce, the PEA calculates an internal rate of return (IRR) of 34% and an after-tax cash flow of USD 71 million. According to Scharf, the IRR is even above 50% at current prices. Thanks to low all-in sustaining costs of around USD 1,350 per ounce, the project has high leverage to the gold price. The reason for the 'small' PEA is that Desert is pursuing a modular processing strategy. Mobile open-pit mining equipment will enable the Company to start production quickly and remain flexible. The current permit allows for the processing of up to 36,000 tons per month – a capacity expansion is possible and could significantly accelerate cash flow. At the same time, the current gold resource of 1.1 million ounces at the SMSZ project could be significantly expanded. This is because only 5 of the more than 30 known gold zones have been included in the resource estimate to date. Scharf is also optimistic about Desert Gold's second project. Exploration is scheduled to begin after the end of the rainy season in Côte d'Ivoire. Link to interview. This should keep Desert Gold on track in terms of operations. Analysts at GBC Research see the fair value of the share at CAD 0.425. The security is currently trading at CAD 0.08 and is listed on Tradegate in Germany, among other places. RENK: One defense company that delivers At least one German defense company is already benefiting from the supercycle. RENK posted impressive figures for the first half of 2025 yesterday. The order intake in particular caused jubilation on the stock market, rising by 46.8% to EUR 921 million in the reporting period. Rheinmetall and Hensoldt had previously opened their books, and their order intake had caused disillusionment and led to hopes being pinned on the second half of the year. As a result, RENK shares rose by more than 5% yesterday. The Company, which is known for its transmissions for the Leopard 2 tank, also posted impressive operating results. Revenue rose by 21.5% to EUR 620 million. Adjusted EBIT climbed by 29.4% to EUR 89 million. With a book-to-bill ratio of 1.5x and a total order backlog of EUR 5.9 billion, visibility for the coming quarters has further improved. Given this strong performance, the forecast for the current year was (naturally) confirmed. RENK aims to increase revenue to over EUR 1.3 billion (2024: EUR 1.14 billion). EBIT is expected to be between EUR 210 million and EUR 235 million (2024: EUR 189 million). Bayer: Billion-dollar deal After uncertainty surrounding Bayer's court cases in the US caused its shares to fall last week, this week has seen a return to optimism thanks to positive developments in the pharmaceuticals division. Bayer shares rose by more than 4% yesterday alone. The reason: The Leverkusen-based company has signed a licensing deal with Kumquat Biosciences that could be worth billions. The US biotech company specializes in the KRAS signaling pathway. The KRAS signaling pathway is a central 'control center' in human cells that regulates how they respond to growth and division signals. It is one of the most frequently disrupted signaling pathways in cancer biology. Kumquat Biosciences is developing a small-molecule inhibitor designed to specifically block the KRAS G12D mutant. This mutation is particularly common in pancreatic, colon, and lung cancer and is currently difficult to treat medically. IND (Investigational New Drug) approval for the compound was granted by the US FDA in July 2025. Kumquat intends to conduct the Phase Ia study independently. Bayer will then take over the further development, approval, and marketing of the active ingredient. Bayer could pay Kumquat Biosciences up to USD 1.3 billion in total, but many milestones still need to be achieved. Desert Gold currently offers a great opportunity in the gold sector. The PEA has not yet triggered the expected price explosion, but a sharp upward move may be imminent. According to GBC Research, a multiplication is possible. After Rheinmetall and Hensoldt disappointed, particularly in terms of order intake, RENK's strong figures were important for the entire industry. Meanwhile, Bayer shares have already delivered a solid performance this year. Conflict of interest Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as 'Relevant Persons') may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a 'Transaction'). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company. In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships. For this reason, there is a concrete conflict of interest. The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies. Risk notice Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such. The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user. The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use. Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein. For full disclaimer information, please click here .
